BREWIN DOLPHIN LTD - INOVIO PHARMACEUTICALS INC ownership

INOVIO PHARMACEUTICALS INC's ticker is INO and the CUSIP is 45773H201. A total of 129 filers reported holding INOVIO PHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is 1.16 and the average weighting 0.0%.

Quarter-by-quarter ownership
BREWIN DOLPHIN LTD ownership history of INOVIO PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2021$9,394
-65.8%
1,312
-55.7%
0.00%
-100.0%
Q2 2021$27,458
-0.1%
2,9620.0%0.00%0.0%
Q1 2021$27,487
+136.7%
2,962
+125.8%
0.00%0.0%
Q4 2020$11,611
-33.2%
1,312
-12.4%
0.00%0.0%
Q3 2020$17,377
-89.8%
1,498
-76.2%
0.00%
-92.3%
Q2 2020$169,677
+1408.4%
6,296
+316.4%
0.01%
+1200.0%
Q1 2020$11,249
+876.5%
1,512
+333.2%
0.00%
Q4 2019$1,152
-89.5%
349
-93.5%
0.00%
-100.0%
Q3 2019$10,965
-79.1%
5,349
-70.0%
0.00%
-80.0%
Q2 2019$52,400
-21.2%
17,8230.0%0.01%
-28.6%
Q1 2019$66,480
-71.9%
17,823
-69.9%
0.01%
-77.4%
Q4 2018$236,492
-28.1%
59,1230.0%0.03%
-13.9%
Q3 2018$328,724
+41.8%
59,1230.0%0.04%
+33.3%
Q2 2018$231,762
-16.8%
59,1230.0%0.03%
-20.6%
Q1 2018$278,469
+14.0%
59,1230.0%0.03%
+13.3%
Q4 2017$244,178
-34.9%
59,1230.0%0.03%
-38.8%
Q3 2017$374,84059,1230.05%
Other shareholders
INOVIO PHARMACEUTICALS INC shareholders Q1 2019
NameSharesValueWeighting ↓
Triatomic Management LP 235,000$405,0000.23%
Green Alpha Advisors, LLC 147,380$254,0000.22%
Financial Advocates Investment Management 14,161$628,0000.05%
Virtus ETF Advisers LLC 72,540$125,0000.05%
Cedar Brook Financial Partners, LLC 88,750$153,0940.05%
Rafferty Asset Management, LLC 2,363,189$4,077,0000.04%
Hennion & Walsh Asset Management, Inc. 352,721$608,0000.04%
CAXTON ASSOCIATES LP 130,728$226,0000.03%
Keystone Financial Group 74,058$128,0000.03%
Virtu Financial LLC 130,829$226,0000.02%
View complete list of INOVIO PHARMACEUTICALS INC shareholders